June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Chiasmal syndrome: clinical features in mexican patients, a 5 year review
Author Affiliations & Notes
  • Aline Astorga-Carballo
    Instituto de Oftalmologia Fundación Conde de Valencia I.A.P., Mexico City, Mexico
  • Juan Carlos Serna-Ojeda
    Instituto de Oftalmologia Fundación Conde de Valencia I.A.P., Mexico City, Mexico
  • Mayra F. Camargo
    Instituto de Oftalmologia Fundación Conde de Valencia I.A.P., Mexico City, Mexico
  • Footnotes
    Commercial Relationships Aline Astorga-Carballo, None; Juan Carlos Serna-Ojeda, None; Mayra Camargo, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 5559. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Aline Astorga-Carballo, Juan Carlos Serna-Ojeda, Mayra F. Camargo; Chiasmal syndrome: clinical features in mexican patients, a 5 year review. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):5559.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To evaluate the ocular manifestations of intracranial pathology producing a chiasmal syndrome, for those initially diagnosed or referred to an ophthalmologic institution.

 
Methods
 

An observational and retrospective study was performed with review of the records of all the patients with a diagnosis of chiasmal syndrome at an ophthalmologic reference center in a 5-year period. The variables analyzed included: demographic data, reason for consultation, visual acuity, visual field defect in Goldmann’s perimetry, afferent pupillary defect, changes in the color vision test, characteristics of the optic nerve and cranial imaging.

 
Results
 

104 patients were included with a median age of 52 years (range 4 - 86 years). 54 patients (51.9%) were initially diagnosed because of the ophthalmologic examination, and 50 (48.07%) were referred with the presumptive diagnosis of an intracranial tumor. The median visual acuity at the time of diagnosis was 20/60 in the eye with worst vision, with 41 patients with a vision in one eye severely affected (worst than 20/400). The main symptoms were decreased central vision in 57 patients (54.8%) and changes in the peripheral visual field in 20 (19.2%); other aggregated manifestations like headache and systemic signs for elevated pituitary hormones were present in 10 (9.61%) and 18 cases (17.3%) respectively. Nine patients had a misdiagnosis of glaucoma for years. The most common visual field defect was bitemporal hemianopsia in 59 (56.73%). 54 patients (51.92%) had relative afferent pupillary defect, and in 65 (62.5%) the color vision test was affected. The optic nerve presented changes in 64.4% of the population. Cranial imaging confirmed the presence of an intracranial tumor in 23 cases (22.11%), being the most common pathology a pituitary adenoma.

 
Conclusions
 

Ophthalmologic examination could imply the initial diagnosis of intracranial pathology as the ocular manifestations are varied. Decreased vision is a common reason for consultation in patients with chiasmal syndrome, and other neurologic and systemic findings can be present. Complimentary study findings of intracranial pathology include bitemporal hemianopsia in Goldmann’s perimetry, altered color vision test and diagnostic cranial imaging.

 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×